Proxy Votes Now

Home › Funds › New York Life › NYLI Epoch Capital Growth Fund

NYLI Epoch Capital Growth Fund (MECDX) proxy voting record 2025-2026

Fund family: New York Life · Filed by NEW YORK LIFE INVESTMENTS FUNDS TRUST (CIK 1469192) · SEC series S000054257

Share classes and tickers: MECDX (C000170407), MECEX (C000170408), MECFX (C000170409), MECVX (C000170410)

“With management” counts the items where the fund’s own filing gives management’s recommendation (FOR or AGAINST): 1,413 with, 71 against, 3 abstentions (not counted as with management); 29 items carried no recommendation. Shareholder proposals: 32 FOR, 54 AGAINST, 1 abstained, by the filing’s own vote-source field.

Compared with New York Life as a whole

The same two figures as New York Life’s manager page (58,397 ballot items across 52 funds and accounts), counted the same way for this fund.

2025-2026This fundItemsNew York LifeItems
Voted FOR the board's own proposals (directors, pay, auditor, capital, transactions, fund matters)94.6%1,26592.5%47,807
Backed environmental and social shareholder proposals at US companiesn/a3614.2%772

Where this fund voted differently from most New York Life funds

Each ballot item this fund voted is set against the votes of the other New York Life funds and accounts on the same item (same meeting, same proposal): “most funds” is a strict majority of at least three of them, FOR against AGAINST, WITHHOLD or ABSTAIN, with split votes and items not voted left out. Funds in one family can follow separate voting policies, for example ESG funds, sub-advised funds and funds using pass-through voting.

Voted differently from most New York Life funds on 11 items (1.7% of the 643 items where a comparison was possible).

The most lopsided family majorities first, then the largest companies, then shareholder proposals.
CompanyMeetingItemThis fundMost New York Life fundsMgmtResult
Alphabet Inc.2026-06-05Shareholder Shareholder proposal regarding a report on AI data usage oversightAgainstFOR — 6 of 6 New York Life fundsForNot approved, 12.3% support
Microsoft Corporation2025-12-05Shareholder Report on Data Operations in Human Rights HotspotsAgainstFOR — 10 of 13 New York Life fundsForFailed (calculated), 27.5% support
Microsoft Corporation2025-12-05Shareholder Report on Human Rights Due DiligenceAgainstFOR — 10 of 13 New York Life fundsForFailed (calculated), 26.3% support
Visa Inc.2026-01-27Shareholder Shareholder proposal requesting the Board of Directors to adopt a policy for an independent chair.AgainstFOR — 4 of 5 New York Life fundsForNot approved, 16.2% support
Alphabet Inc.2026-06-05Approval of the amendment and restatement of Alphabet's Amended and Restated 2021 Stock Plan to increase the share reserve by 200,000,000 shares of Class C capital stockForAGAINST — 4 of 6 New York Life fundsForApproved, 90.4% support
Copart, Inc.2025-12-05To elect the twelve nominees for director named in this proxy statement to hold office until our 2026 annual meeting of stockholders or until their respective successors have been duly elected and qualified: Steven D. CohanForAGAINST — 2 of 3 New York Life fundsForElected, 88.4% support
Novo Nordisk A/S2025-11-14Shareholder Elect Britt Meelby Jensen as New DirectorForABSTAIN — 2 of 3 New York Life funds——
Novo Nordisk A/S2025-11-14Shareholder Elect Cees de Jong (Vice Chair) as New DirectorForABSTAIN — 2 of 3 New York Life funds——
Novo Nordisk A/S2025-11-14Shareholder Elect Lars Rebien Sorensen (Chair) as New DirectorForABSTAIN — 2 of 3 New York Life funds——
Novo Nordisk A/S2025-11-14Shareholder Elect Mikael Dolsten as New DirectorForABSTAIN — 2 of 3 New York Life funds——
Novo Nordisk A/S2025-11-14Shareholder Elect Stephan Engels as New DirectorForABSTAIN — 2 of 3 New York Life funds——

Download all 11 differences (CSV)

What it voted on

Ballot items by the category the filing put first; “against management” as above.
Proposal typeItemsAgainst management
Director Elections9000
Corporate Governance18927
Compensation1052
Audit-related1030
Capital Structure990
Say-on-Pay710
Other Social Issues2320
Environment or Climate1212
Shareholder Rights and Defenses94
Human Rights or Human Capital/workforce66

Its largest holdings’ meetings

Position = shares voted × a recent share price, for US-listed shares of companies with a page on this site; an estimate for ranking only.

CompanyMeetingEst. positionItemsAgainst mgmt
Lam Research CorporationNovember 4, 2025$5M161
Apple Inc.February 24, 2026$4M121
NVIDIA CorporationJune 24, 2026$4M164
Meta Platforms, Inc.May 27, 2026$3M229
Regeneron Pharmaceuticals, Inc.June 12, 2026$3M70
AbbVie Inc.May 8, 2026$3M81
West Pharmaceutical Services, Inc.May 4, 2026$3M141
Mastercard IncorporatedJune 16, 2026$2M152

Notable votes against management

MeetingCompanyProposalFundMgmt
November 4, 2025Lam Research CorporationStockholder proposal titled "Realistic Shareholder Ability to Call for a Special Shareholder Meeting," if properly presented. Shareholder proposalForAgainst
February 24, 2026Apple Inc.A shareholder proposal entitled "China Entanglement Audit" Shareholder proposalAgainstFor
June 24, 2026NVIDIA CorporationApproval of a non-binding stockholder proposal requesting the replacement of supermajority voting provisions in our charter and bylaws with a simple majority voting standard. Shareholder proposalForAgainst
June 24, 2026NVIDIA CorporationApproval of a non-binding stockholder proposal requesting a report on faith-based community resource groups. Shareholder proposalAgainstFor
May 27, 2026Meta Platforms, Inc.A shareholder proposal regarding report on Al data usage oversight. Shareholder proposalAgainstFor
May 27, 2026Meta Platforms, Inc.A shareholder proposal regarding annual vote regarding executive pay. Shareholder proposalForAgainst
May 8, 2026AbbVie Inc.Stockholder Proposal - to Adopt a Policy to Require an Independent Chair Shareholder proposalForAgainst
May 4, 2026West Pharmaceutical Services, Inc.Shareholder proposal regarding an independent Board Chair policy. Shareholder proposalForAgainst
June 16, 2026Mastercard IncorporatedConsideration of a stockholder proposal regarding shareholder right to act by written consent Shareholder proposalForAgainst
June 16, 2026Mastercard IncorporatedConsideration of a stockholder proposal to adopt cumulative voting for the election of directors Shareholder proposalAgainstFor
September 10, 2025NetApp, Inc.To approve a stockholder proposal regarding support for Special Shareholder Meeting Improvement. Shareholder proposalAgainstFor
December 5, 2025Microsoft CorporationEuropean Security Program Censorship Risk Audit Shareholder proposalAgainstFor

Search this fund’s votes by company

1,521 ballot items at 117 meetings in 2025-2026. Download all votes (CSV)

Recent notable votes

Recent votes against management’s recommendation at large companies.

About this fund’s record

In the 2025-2026 proxy season, NYLI Epoch Capital Growth Fund (MECDX) voted at 117 shareholder meetings of 108 companies, on 1,521 ballot items in all. Where management made a recommendation, the fund followed it on 95.0% of the items and voted against it 71 times. Its most frequent area of disagreement was corporate governance (27 of its votes against management). It voted FOR 37.2% of the 86 shareholder proposals on which it cast a FOR or AGAINST vote. It voted FOR the board's own proposals more often than New York Life's funds as a whole (94.6% against 92.5%). It voted differently from most New York Life funds on 11 items.

About this page

Every figure is derived from the fund’s own Form N-PX filings with the SEC, read item by item: one ballot item is the fund’s vote on one proposal at one meeting, and an item filed twice in the season is counted once. Percentages count items, never shares. A season is published only with at least 250 ballot items at 15 meetings. Built November 18, 2026; the family figures are those of New York Life’s manager page. The interactive database shows the same votes company by company, with every other fund that voted.